Skip to main content
. 2019 Dec 31;267(4):1097–1102. doi: 10.1007/s00415-019-09684-4

Table 2.

Clinical-demographic characteristics at baseline in the whole cohort and in the hereditary/sporadic subgroups

Whole cohort (n = 42) Hereditary (n = 23) Sporadic (n = 19) Statistic
Age at examination 53 ± 13 47 ± 12 61 ± 10 0.67
Sex (females, %) 13 (31%) 6 (25%) 7 (39%) 0.52
Age at onset 46 (28;56) 33 ± 15 53 ± 8 0.003
Disease duration 10 (3;15) 13 (7;19) 3 (2;14) 0.008
Death during follow-up (no. of cases) 2 (4.7%) 0 2 (10.5%) 0.2
SARA 13.5 (9;17.5) 14 ± 7 14 ± 5 0.08
UMSARS I 7.5 (5;12) 5 (3;10) 9 (6;14) 0.04
UMSARS II 16.3 ± 7.4 12 (10;19) 19 (12;21) 0.29
SCOPA-Aut 7 (3;14) 4 (3;12) 12 (7;15) 0.03
OHQ 0 (0;4) 0 (0;2.5) 0 (0;5.3) 0.32

Statistically significant differences are reported in bold